CPHI 2026 – 23/07/2026
PCI Drug-Device 28/05/2026

Current Edition

ramusmedical
Regional News

JPM 2022: Vertex’s Trikafta holds the line as company lays groundwork for gene editing launch

Vertex Pharmaceuticals is well known for its slew of cystic fibrosis medications, and newcomer Trikafta is pulling its weight. Over the course of 2021, the med clinch...
Continue Reading →
Quotient
CPHI 2026 – 20/07/2026